MedTrace Logo

GLucose Monitoring Programme SingaporeE (GLiMPSE)

NCT03837262 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2020-09-09

No results posted yet for this study

Summary

This phase 1 study is a non-randomized, single-arm, multi-center study that is designed to evaluate the feasibility and acceptability of the flash glucose monitoring system together with a structured education programme in individuals with Type 2 Diabetes.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

COMBINATION_PRODUCT

Flash Glucose Monitoring and structured education

A feasibility study assessing the use of flash glucose sensing technology with structured education to improve glycemic outcomes in T2D adults and children

Sponsors & Collaborators

  • KK Women's and Children's Hospital

    collaborator OTHER_GOV

  • SingHealth Polyclinics

    collaborator OTHER

  • Singapore General Hospital

    lead OTHER

Principal Investigators

  • Daphne SL Gardner, MD · Singapore General Hospital, SingHealth

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-25
Primary Completion
2020-01-23
Completion
2020-04-30

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03837262 on ClinicalTrials.gov